nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Abrasion NOS—Galantamine—Alzheimer's disease	0.0371	0.0499	CcSEcCtD
Fluocinolone Acetonide—Abrasion NOS—Donepezil—Alzheimer's disease	0.0288	0.0387	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Tetrabenazine—Donepezil—Alzheimer's disease	0.0262	1	CbGdCrCtD
Fluocinolone Acetonide—Abrasion NOS—Memantine—Alzheimer's disease	0.0261	0.0351	CcSEcCtD
Fluocinolone Acetonide—Condition aggravated—Memantine—Alzheimer's disease	0.0235	0.0316	CcSEcCtD
Fluocinolone Acetonide—Excoriation—Galantamine—Alzheimer's disease	0.0202	0.0271	CcSEcCtD
Fluocinolone Acetonide—Common cold—Donepezil—Alzheimer's disease	0.0181	0.0243	CcSEcCtD
Fluocinolone Acetonide—Retinal detachment—Memantine—Alzheimer's disease	0.0164	0.0221	CcSEcCtD
Fluocinolone Acetonide—Excoriation—Donepezil—Alzheimer's disease	0.0156	0.021	CcSEcCtD
Fluocinolone Acetonide—Skin striae—Donepezil—Alzheimer's disease	0.0148	0.02	CcSEcCtD
Fluocinolone Acetonide—Retinal haemorrhage—Donepezil—Alzheimer's disease	0.0145	0.0195	CcSEcCtD
Fluocinolone Acetonide—Conjunctival haemorrhage—Donepezil—Alzheimer's disease	0.0145	0.0195	CcSEcCtD
Fluocinolone Acetonide—Excoriation—Memantine—Alzheimer's disease	0.0142	0.0191	CcSEcCtD
Fluocinolone Acetonide—Conjunctival haemorrhage—Memantine—Alzheimer's disease	0.0131	0.0177	CcSEcCtD
Fluocinolone Acetonide—Retinal haemorrhage—Memantine—Alzheimer's disease	0.0131	0.0177	CcSEcCtD
Fluocinolone Acetonide—Conjunctival haemorrhage—Rivastigmine—Alzheimer's disease	0.0129	0.0173	CcSEcCtD
Fluocinolone Acetonide—Fungal skin infection—Donepezil—Alzheimer's disease	0.0113	0.0152	CcSEcCtD
Fluocinolone Acetonide—Skin irritation—Rivastigmine—Alzheimer's disease	0.00969	0.013	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Donepezil—Alzheimer's disease	0.00767	0.0103	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Memantine—Alzheimer's disease	0.0072	0.00969	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Memantine—Alzheimer's disease	0.00697	0.00937	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Rivastigmine—Alzheimer's disease	0.00682	0.00917	CcSEcCtD
Fluocinolone Acetonide—Cataract—Galantamine—Alzheimer's disease	0.0064	0.00861	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Donepezil—Alzheimer's disease	0.00627	0.00843	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Donepezil—Alzheimer's disease	0.00606	0.00815	CcSEcCtD
Fluocinolone Acetonide—Abscess—Donepezil—Alzheimer's disease	0.00597	0.00802	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Donepezil—Alzheimer's disease	0.00592	0.00796	CcSEcCtD
Fluocinolone Acetonide—Mania—Memantine—Alzheimer's disease	0.00589	0.00793	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Memantine—Alzheimer's disease	0.00569	0.00766	CcSEcCtD
Fluocinolone Acetonide—Glaucoma—Rivastigmine—Alzheimer's disease	0.00557	0.00749	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Donepezil—Alzheimer's disease	0.00553	0.00743	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Memantine—Alzheimer's disease	0.0055	0.0074	CcSEcCtD
Fluocinolone Acetonide—Abscess—Memantine—Alzheimer's disease	0.00542	0.00729	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Rivastigmine—Alzheimer's disease	0.00539	0.00724	CcSEcCtD
Fluocinolone Acetonide—Abscess—Rivastigmine—Alzheimer's disease	0.0053	0.00713	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Galantamine—Alzheimer's disease	0.00499	0.00671	CcSEcCtD
Fluocinolone Acetonide—Cataract—Donepezil—Alzheimer's disease	0.00496	0.00667	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Rivastigmine—Alzheimer's disease	0.00464	0.00624	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Donepezil—Alzheimer's disease	0.00458	0.00617	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Rivastigmine—Alzheimer's disease	0.00455	0.00612	CcSEcCtD
Fluocinolone Acetonide—Cataract—Memantine—Alzheimer's disease	0.0045	0.00606	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Galantamine—Alzheimer's disease	0.00442	0.00595	CcSEcCtD
Fluocinolone Acetonide—Cataract—Rivastigmine—Alzheimer's disease	0.0044	0.00592	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Donepezil—Alzheimer's disease	0.00436	0.00586	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.00414	0.00557	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Donepezil—Alzheimer's disease	0.00402	0.0054	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Donepezil—Alzheimer's disease	0.00387	0.0052	CcSEcCtD
Fluocinolone Acetonide—Eczema—Donepezil—Alzheimer's disease	0.00381	0.00513	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Memantine—Alzheimer's disease	0.00365	0.0049	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Rivastigmine—Alzheimer's disease	0.00357	0.0048	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00355	0.00478	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00351	0.00472	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Memantine—Alzheimer's disease	0.00351	0.00472	CcSEcCtD
Fluocinolone Acetonide—Eczema—Memantine—Alzheimer's disease	0.00346	0.00466	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Memantine—Alzheimer's disease	0.00345	0.00463	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00343	0.00462	CcSEcCtD
Fluocinolone Acetonide—Eczema—Rivastigmine—Alzheimer's disease	0.00339	0.00455	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Rivastigmine—Alzheimer's disease	0.00337	0.00453	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Memantine—Alzheimer's disease	0.00319	0.00429	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00312	0.00419	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Memantine—Alzheimer's disease	0.00311	0.00418	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Memantine—Alzheimer's disease	0.00311	0.00418	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Galantamine—Alzheimer's disease	0.00307	0.00412	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00306	0.00412	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00304	0.00409	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Rivastigmine—Alzheimer's disease	0.00304	0.00409	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00301	0.00404	CcSEcCtD
Fluocinolone Acetonide—Influenza—Donepezil—Alzheimer's disease	0.00296	0.00398	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Galantamine—Alzheimer's disease	0.00295	0.00396	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Galantamine—Alzheimer's disease	0.00286	0.00384	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Memantine—Alzheimer's disease	0.00278	0.00374	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00272	0.00366	CcSEcCtD
Fluocinolone Acetonide—Influenza—Memantine—Alzheimer's disease	0.00269	0.00362	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Galantamine—Alzheimer's disease	0.00268	0.0036	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Galantamine—Alzheimer's disease	0.00266	0.00358	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Donepezil—Alzheimer's disease	0.00264	0.00355	CcSEcCtD
Fluocinolone Acetonide—Infestation—Donepezil—Alzheimer's disease	0.00264	0.00355	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Galantamine—Alzheimer's disease	0.00261	0.00351	CcSEcCtD
Fluocinolone Acetonide—Back pain—Galantamine—Alzheimer's disease	0.00258	0.00346	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Galantamine—Alzheimer's disease	0.00251	0.00337	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.0025	0.00336	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00244	0.00329	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Memantine—Alzheimer's disease	0.0024	0.00322	CcSEcCtD
Fluocinolone Acetonide—Infestation—Memantine—Alzheimer's disease	0.0024	0.00322	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Galantamine—Alzheimer's disease	0.00239	0.00322	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Donepezil—Alzheimer's disease	0.00238	0.0032	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00235	0.00315	CcSEcCtD
Fluocinolone Acetonide—Infestation—Rivastigmine—Alzheimer's disease	0.00235	0.00315	CcSEcCtD
Fluocinolone Acetonide—Cough—Galantamine—Alzheimer's disease	0.00232	0.00312	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Donepezil—Alzheimer's disease	0.00228	0.00307	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Galantamine—Alzheimer's disease	0.00227	0.00305	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Memantine—Alzheimer's disease	0.00225	0.00303	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Rivastigmine—Alzheimer's disease	0.0022	0.00296	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Memantine—Alzheimer's disease	0.00216	0.0029	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Galantamine—Alzheimer's disease	0.00213	0.00287	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Memantine—Alzheimer's disease	0.00211	0.00284	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Rivastigmine—Alzheimer's disease	0.00211	0.00284	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Donepezil—Alzheimer's disease	0.00209	0.00282	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Donepezil—Alzheimer's disease	0.00208	0.00279	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Memantine—Alzheimer's disease	0.00207	0.00279	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00207	0.00278	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Donepezil—Alzheimer's disease	0.00206	0.00278	CcSEcCtD
Fluocinolone Acetonide—Erythema—Donepezil—Alzheimer's disease	0.00206	0.00278	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Rivastigmine—Alzheimer's disease	0.00203	0.00273	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Donepezil—Alzheimer's disease	0.00202	0.00272	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Memantine—Alzheimer's disease	0.00201	0.00271	CcSEcCtD
Fluocinolone Acetonide—Back pain—Donepezil—Alzheimer's disease	0.002	0.00268	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00198	0.00266	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Rivastigmine—Alzheimer's disease	0.00197	0.00265	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Donepezil—Alzheimer's disease	0.00194	0.00262	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Memantine—Alzheimer's disease	0.00194	0.00261	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Memantine—Alzheimer's disease	0.0019	0.00256	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.0019	0.00255	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Memantine—Alzheimer's disease	0.00189	0.00254	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00188	0.00252	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Memantine—Alzheimer's disease	0.00187	0.00252	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Rivastigmine—Alzheimer's disease	0.00186	0.0025	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Donepezil—Alzheimer's disease	0.00185	0.00249	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Rivastigmine—Alzheimer's disease	0.00184	0.00248	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Memantine—Alzheimer's disease	0.00183	0.00247	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Rivastigmine—Alzheimer's disease	0.00183	0.00247	CcSEcCtD
Fluocinolone Acetonide—Erythema—Rivastigmine—Alzheimer's disease	0.00183	0.00247	CcSEcCtD
Fluocinolone Acetonide—Back pain—Memantine—Alzheimer's disease	0.00181	0.00244	CcSEcCtD
Fluocinolone Acetonide—Cough—Donepezil—Alzheimer's disease	0.0018	0.00242	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00179	0.00241	CcSEcCtD
Fluocinolone Acetonide—Back pain—Rivastigmine—Alzheimer's disease	0.00177	0.00238	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Memantine—Alzheimer's disease	0.00177	0.00237	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Donepezil—Alzheimer's disease	0.00176	0.00236	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Rivastigmine—Alzheimer's disease	0.00173	0.00232	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Galantamine—Alzheimer's disease	0.00172	0.00231	CcSEcCtD
Fluocinolone Acetonide—Oedema—Donepezil—Alzheimer's disease	0.00168	0.00227	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Memantine—Alzheimer's disease	0.00168	0.00226	CcSEcCtD
Fluocinolone Acetonide—Infection—Donepezil—Alzheimer's disease	0.00167	0.00225	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Donepezil—Alzheimer's disease	0.00165	0.00222	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Rivastigmine—Alzheimer's disease	0.00165	0.00221	CcSEcCtD
Fluocinolone Acetonide—Cough—Memantine—Alzheimer's disease	0.00163	0.0022	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Galantamine—Alzheimer's disease	0.0016	0.00215	CcSEcCtD
Fluocinolone Acetonide—Cough—Rivastigmine—Alzheimer's disease	0.0016	0.00215	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Memantine—Alzheimer's disease	0.00159	0.00215	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Rivastigmine—Alzheimer's disease	0.00156	0.0021	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00153	0.00206	CcSEcCtD
Fluocinolone Acetonide—Oedema—Memantine—Alzheimer's disease	0.00153	0.00206	CcSEcCtD
Fluocinolone Acetonide—Infection—Memantine—Alzheimer's disease	0.00152	0.00204	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Memantine—Alzheimer's disease	0.0015	0.00202	CcSEcCtD
Fluocinolone Acetonide—Oedema—Rivastigmine—Alzheimer's disease	0.0015	0.00201	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Galantamine—Alzheimer's disease	0.00149	0.002	CcSEcCtD
Fluocinolone Acetonide—Infection—Rivastigmine—Alzheimer's disease	0.00149	0.002	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00147	0.00197	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00145	0.00196	CcSEcCtD
Fluocinolone Acetonide—Pain—Donepezil—Alzheimer's disease	0.00144	0.00194	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Galantamine—Alzheimer's disease	0.00144	0.00193	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00139	0.00187	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Galantamine—Alzheimer's disease	0.00138	0.00186	CcSEcCtD
Fluocinolone Acetonide—Rash—Galantamine—Alzheimer's disease	0.00137	0.00184	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Galantamine—Alzheimer's disease	0.00137	0.00184	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00136	0.00183	CcSEcCtD
Fluocinolone Acetonide—Headache—Galantamine—Alzheimer's disease	0.00136	0.00183	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Donepezil—Alzheimer's disease	0.00133	0.00179	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00132	0.00178	CcSEcCtD
Fluocinolone Acetonide—Pain—Memantine—Alzheimer's disease	0.00131	0.00176	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00129	0.00174	CcSEcCtD
Fluocinolone Acetonide—Nausea—Galantamine—Alzheimer's disease	0.00129	0.00174	CcSEcCtD
Fluocinolone Acetonide—Pain—Rivastigmine—Alzheimer's disease	0.00128	0.00172	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00124	0.00167	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Memantine—Alzheimer's disease	0.00121	0.00163	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Donepezil—Alzheimer's disease	0.00119	0.0016	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00118	0.00159	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Donepezil—Alzheimer's disease	0.00115	0.00155	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Memantine—Alzheimer's disease	0.00113	0.00152	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Donepezil—Alzheimer's disease	0.00111	0.0015	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.0011	0.00148	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Memantine—Alzheimer's disease	0.00108	0.00146	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Donepezil—Alzheimer's disease	0.00107	0.00144	CcSEcCtD
Fluocinolone Acetonide—Rash—Donepezil—Alzheimer's disease	0.00106	0.00143	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Donepezil—Alzheimer's disease	0.00106	0.00143	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Rivastigmine—Alzheimer's disease	0.00106	0.00142	CcSEcCtD
Fluocinolone Acetonide—Headache—Donepezil—Alzheimer's disease	0.00105	0.00142	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Memantine—Alzheimer's disease	0.00105	0.00141	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00102	0.00138	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Memantine—Alzheimer's disease	0.00101	0.00136	CcSEcCtD
Fluocinolone Acetonide—Nausea—Donepezil—Alzheimer's disease	0.001	0.00135	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Rivastigmine—Alzheimer's disease	0.000989	0.00133	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Memantine—Alzheimer's disease	0.000972	0.00131	CcSEcCtD
Fluocinolone Acetonide—Rash—Memantine—Alzheimer's disease	0.000964	0.0013	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Memantine—Alzheimer's disease	0.000963	0.0013	CcSEcCtD
Fluocinolone Acetonide—Headache—Memantine—Alzheimer's disease	0.000958	0.00129	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Rivastigmine—Alzheimer's disease	0.000951	0.00128	CcSEcCtD
Fluocinolone Acetonide—Rash—Rivastigmine—Alzheimer's disease	0.000943	0.00127	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000942	0.00127	CcSEcCtD
Fluocinolone Acetonide—Headache—Rivastigmine—Alzheimer's disease	0.000937	0.00126	CcSEcCtD
Fluocinolone Acetonide—Nausea—Memantine—Alzheimer's disease	0.000908	0.00122	CcSEcCtD
Fluocinolone Acetonide—Nausea—Rivastigmine—Alzheimer's disease	0.000888	0.0012	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000844	0.0037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—NOS3—Alzheimer's disease	0.000835	0.00366	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000823	0.00361	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000814	0.00357	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Opioid Signalling—CREB1—Alzheimer's disease	0.000812	0.00356	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000805	0.00353	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000791	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000791	0.00347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TF—Alzheimer's disease	0.00079	0.00346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000786	0.00345	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000785	0.00344	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000783	0.00343	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000763	0.00334	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000755	0.00331	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000747	0.00327	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000739	0.00324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—NOS3—Alzheimer's disease	0.00073	0.0032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—GAB2—Alzheimer's disease	0.000723	0.00317	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000718	0.00315	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.00071	0.00311	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.000709	0.00311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—CASP3—Alzheimer's disease	0.000709	0.00311	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—APP—Alzheimer's disease	0.000704	0.00309	CbGpPWpGaD
Fluocinolone Acetonide—Triamcinolone—BCHE—Alzheimer's disease	0.000695	0.324	CrCbGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000694	0.00304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK8—Alzheimer's disease	0.000694	0.00304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CDK5—Alzheimer's disease	0.00068	0.00298	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—MAPK8—Alzheimer's disease	0.000676	0.00296	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000676	0.00296	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000676	0.00296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—MAPK8—Alzheimer's disease	0.000651	0.00285	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000646	0.00283	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000639	0.0028	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000632	0.00277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000606	0.00266	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.0006	0.00263	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000575	0.00252	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	0.000574	0.00252	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.000574	0.00251	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000569	0.00249	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000564	0.00247	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000549	0.00241	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000547	0.0024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	0.000545	0.00239	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000542	0.00237	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CLU—Alzheimer's disease	0.000537	0.00236	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—NOS2—Alzheimer's disease	0.000532	0.248	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—DHCR24—Alzheimer's disease	0.000525	0.0023	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000519	0.00227	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000504	0.00221	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000491	0.00215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000489	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000484	0.00212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—A2M—Alzheimer's disease	0.000479	0.0021	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000468	0.00205	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000458	0.00201	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000455	0.00199	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PYY—Alzheimer's disease	0.00045	0.00197	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000448	0.00196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CA4—Alzheimer's disease	0.000446	0.00196	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000436	0.00191	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000426	0.00187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000425	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GAPDHS—Alzheimer's disease	0.000419	0.00184	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—INPP5D—Alzheimer's disease	0.000412	0.00181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000409	0.00179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—Alzheimer's disease	0.000409	0.00179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TF—Alzheimer's disease	0.000407	0.00178	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000406	0.00178	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.0004	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000399	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—Alzheimer's disease	0.000398	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ATP5A1—Alzheimer's disease	0.000398	0.00174	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.000394	0.00173	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000393	0.00172	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000391	0.00172	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—Alzheimer's disease	0.000391	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CDK5—Alzheimer's disease	0.00039	0.00171	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000387	0.0017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—Alzheimer's disease	0.000384	0.00168	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000381	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLD3—Alzheimer's disease	0.000379	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000379	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000379	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000376	0.00165	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000375	0.00165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000375	0.00164	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000373	0.00163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GAB2—Alzheimer's disease	0.000372	0.00163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD17B10—Alzheimer's disease	0.000364	0.00159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APP—Alzheimer's disease	0.000363	0.00159	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000355	0.00156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP46A1—Alzheimer's disease	0.00035	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.00035	0.00153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000343	0.00151	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00034	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ND1—Alzheimer's disease	0.000338	0.00148	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00033	0.00145	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000326	0.00143	CbGpPWpGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—Alzheimer's disease	0.00032	0.149	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAL—Alzheimer's disease	0.000312	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000307	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TTR—Alzheimer's disease	0.000304	0.00133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000303	0.00133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000302	0.00132	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SOD1—Alzheimer's disease	0.000296	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—Alzheimer's disease	0.000281	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000281	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000278	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.00027	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PYY—Alzheimer's disease	0.000266	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—Alzheimer's disease	0.000262	0.122	CrCbGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.000262	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000261	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000257	0.00113	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCG—Alzheimer's disease	0.000253	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000252	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000252	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.000247	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NPY—Alzheimer's disease	0.000245	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000243	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000237	0.00104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CRH—Alzheimer's disease	0.000236	0.00104	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000236	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDK5—Alzheimer's disease	0.00023	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.00023	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	0.000229	0.001	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000228	0.001	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000227	0.000995	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NPS—Alzheimer's disease	0.000224	0.000982	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000223	0.000977	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR6—Alzheimer's disease	0.000222	0.000972	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAU—Alzheimer's disease	0.000222	0.000971	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.00022	0.000965	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CALM1—Alzheimer's disease	0.000219	0.00096	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CHAT—Alzheimer's disease	0.000218	0.000955	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TPI1—Alzheimer's disease	0.000218	0.000955	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CAV1—Alzheimer's disease	0.000216	0.000948	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000214	0.000937	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000214	0.000937	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SST—Alzheimer's disease	0.000214	0.000937	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000212	0.000929	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	0.00021	0.00092	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MAOB—Alzheimer's disease	0.000209	0.000916	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—APP—Alzheimer's disease	0.000208	0.000913	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—F2—Alzheimer's disease	0.000206	0.000903	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—Alzheimer's disease	0.000203	0.000892	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSENEN—Alzheimer's disease	0.000201	0.000883	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GAPDH—Alzheimer's disease	0.000201	0.000881	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000199	0.000871	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APH1A—Alzheimer's disease	0.000199	0.000871	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000197	0.000863	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000197	0.000862	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—A2M—Alzheimer's disease	0.000194	0.000851	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000194	0.000851	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000193	0.000848	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LRP1—Alzheimer's disease	0.000189	0.000827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GFAP—Alzheimer's disease	0.000184	0.000808	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAL—Alzheimer's disease	0.000184	0.000808	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000183	0.000803	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP2D6—Alzheimer's disease	0.000182	0.0848	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—Alzheimer's disease	0.00018	0.000791	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000173	0.000759	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000171	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ACHE—Alzheimer's disease	0.000169	0.00074	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INPP5D—Alzheimer's disease	0.000167	0.000732	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000164	0.000719	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—Alzheimer's disease	0.000164	0.000717	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—A2M—Alzheimer's disease	0.000162	0.000712	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00016	0.0007	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ENO1—Alzheimer's disease	0.000158	0.000694	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS1—Alzheimer's disease	0.000158	0.000694	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000157	0.00069	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000157	0.000689	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2D6—Alzheimer's disease	0.000155	0.00068	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000154	0.000677	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—Alzheimer's disease	0.000153	0.0712	CrCbGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000148	0.000648	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—Alzheimer's disease	0.000147	0.000645	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.000146	0.000639	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000146	0.000639	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000145	0.000637	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY—Alzheimer's disease	0.000145	0.000634	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IAPP—Alzheimer's disease	0.000144	0.00063	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRH—Alzheimer's disease	0.00014	0.000612	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCB1—Alzheimer's disease	0.000139	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000138	0.000604	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000136	0.000597	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000135	0.000591	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCA1—Alzheimer's disease	0.000135	0.00059	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPS—Alzheimer's disease	0.000132	0.00058	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000132	0.000577	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTK2B—Alzheimer's disease	0.00013	0.000569	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAB2—Alzheimer's disease	0.000126	0.000553	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SST—Alzheimer's disease	0.000126	0.000553	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000126	0.000553	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000126	0.000551	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000125	0.000549	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APP—Alzheimer's disease	0.000123	0.000539	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—F2—Alzheimer's disease	0.000118	0.000518	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—Alzheimer's disease	0.000118	0.000517	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000116	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARGC1A—Alzheimer's disease	0.000116	0.000508	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—Alzheimer's disease	0.000115	0.000506	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGFR—Alzheimer's disease	0.000108	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—Alzheimer's disease	0.000108	0.000474	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000108	0.000472	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000106	0.000464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—Alzheimer's disease	0.000106	0.000463	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000105	0.000462	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—S100B—Alzheimer's disease	0.0001	0.000439	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—Alzheimer's disease	9.53e-05	0.000418	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MTHFR—Alzheimer's disease	9.51e-05	0.000417	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1R—Alzheimer's disease	9.21e-05	0.000404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—Alzheimer's disease	8.91e-05	0.00039	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CALM1—Alzheimer's disease	8.88e-05	0.000389	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—Alzheimer's disease	8.85e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—Alzheimer's disease	8.83e-05	0.000387	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAV1—Alzheimer's disease	8.77e-05	0.000384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MEF2C—Alzheimer's disease	8.75e-05	0.000384	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCG—Alzheimer's disease	8.59e-05	0.000376	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGF—Alzheimer's disease	8.36e-05	0.000367	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR5—Alzheimer's disease	8.14e-05	0.000357	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—Alzheimer's disease	7.96e-05	0.000349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—Alzheimer's disease	7.71e-05	0.000338	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—ESR1—Alzheimer's disease	7.69e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—Alzheimer's disease	7.56e-05	0.000332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—Alzheimer's disease	7.52e-05	0.00033	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	7.43e-05	0.000326	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CALM1—Alzheimer's disease	7.43e-05	0.000326	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—Alzheimer's disease	7.4e-05	0.000324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—Alzheimer's disease	7.4e-05	0.000324	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CAV1—Alzheimer's disease	7.33e-05	0.000321	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ESR1—Alzheimer's disease	7.07e-05	0.00031	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—Alzheimer's disease	7.02e-05	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—F2—Alzheimer's disease	6.98e-05	0.000306	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.83e-05	0.000299	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—Alzheimer's disease	6.63e-05	0.000291	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GSK3B—Alzheimer's disease	6.41e-05	0.000281	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CREB1—Alzheimer's disease	6.36e-05	0.000279	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—Alzheimer's disease	6.32e-05	0.000277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—Alzheimer's disease	6.22e-05	0.000273	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—Alzheimer's disease	6.12e-05	0.000268	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—Alzheimer's disease	6.07e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—Alzheimer's disease	5.55e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—Alzheimer's disease	4.71e-05	0.000206	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—Alzheimer's disease	4.68e-05	0.000205	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAPK8—Alzheimer's disease	4.33e-05	0.00019	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—Alzheimer's disease	4.32e-05	0.000189	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—Alzheimer's disease	4e-05	0.000175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—Alzheimer's disease	3.67e-05	0.000161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—Alzheimer's disease	3.05e-05	0.000134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—Alzheimer's disease	3.02e-05	0.000132	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—Alzheimer's disease	2.77e-05	0.000122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—Alzheimer's disease	2.76e-05	0.000121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—Alzheimer's disease	2.55e-05	0.000112	CbGpPWpGaD
